
Ask a doctor about a prescription for LORATADINE TEVA-RATIOPHARM 10 mg TABLETS
Package Leaflet: Information for the User
Loratadina Teva-ratiopharm 10 mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
5. Storage of Loratadina Teva-ratiopharm
The full name of this medicine is Loratadina Teva-ratiopharm 10 mg Tablets.
What is Loratadina Teva-ratiopharm
Loratadina Teva-ratiopharm contains the active substance loratadine, which belongs to a class of medicines called “antihistamines”.
How Loratadina Teva-ratiopharm works
Loratadina Teva-ratiopharm helps to relieve your allergy symptoms by blocking the effects of a substance called histamine, which is produced by your body when you are allergic to something.
When to take Loratadina Teva-ratiopharm
Loratadina Teva-ratiopharm relieves the symptoms of allergic rhinitis (e.g. hay fever) such as sneezing, runny or itchy nose, and itchy or watery eyes in adults and children aged 6 years and older who weigh more than 30 kg.
Loratadina Teva-ratiopharm can also be used to help relieve the symptoms of urticaria (itching, redness of the skin) and the number and size of skin eruptions.
The effect of Loratadina Teva-ratiopharm lasts all day and will help you to continue with your normal activities and sleep.
You should consult your doctor if it worsens or does not improve.
Do not take Loratadina Teva-ratiopharm
Warnings and precautions
Consult your doctor, pharmacist or nurse before taking Loratadina Teva-ratiopharm if:
If you are in any of the above situations (or are unsure), please consult your doctor, pharmacist or nurse before taking Loratadina Teva-ratiopharm.
Children
Do not give Loratadina Teva-ratiopharm to children under 6 years of age or children who weigh 30 kg or less. There are other formulations more suitable for children under 6 years of age who weigh 30 kg or less.
Children under 2 years of age
The safety and efficacy of Loratadina Teva-ratiopharm have not been established. No data are available.
Taking Loratadina Teva-ratiopharm with other medicines
The side effects of loratadine may increase when taken with medicines that affect the performance of certain enzymes found in the liver, or if your liver is not working properly. In clinical studies, no increase in the side effects of loratadine was observed with medicines that affect the performance of these enzymes.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Taking Loratadina Teva-ratiopharm with alcohol
It has not been shown that loratadine increases the effects of alcoholic drinks.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
As a precaution, it is recommended to avoid taking loratadine if you are pregnant.
Do not take Loratadina Teva-ratiopharm if you are breast-feeding. Loratadine is excreted in breast milk.
Driving and using machines
In clinical trials that evaluated driving ability, no reduced function was observed in patients who received loratadine. At the recommended dose, it is not expected that Loratadina Teva-ratiopharm will cause drowsiness or reduced alertness. However, very rarely some people may experience drowsiness, which may affect their ability to drive or use machines.
Loratadina Teva-ratiopharm contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. If you are not sure, ask your doctor, pharmacist or nurse.
The score line is only to help you break the tablet if you have difficulty swallowing it whole.
The recommended dose is:
Adults and children over 6 years of age with a body weight of more than 30 kg:
Take 1 tablet once a day with a glass of water, with or without food.
Body weight of 30 kg or less:
Do not give Loratadina Teva-ratiopharm. There are other formulations more suitable for children under 6 years of age who weigh 30 kg or less.
Children under 2 years of age:
Loratadina Teva-ratiopharm is not recommended for children under 2 years of age.
Adults and children with severe liver problems:
Adults and children who weigh more than 30 kg
Take 1 tablet once a day, every other day, with a glass of water, with or without food.
However, you should consult your doctor, pharmacist or nurse before taking this medicine.
If you take more Loratadina Teva-ratiopharm than you should
If you take more Loratadina Teva-ratiopharm than you should, talk to your doctor or pharmacist immediately. No serious problems are expected with accidental overdose. However, you may experience headache, palpitations or drowsiness.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone (91) 562 04 20, stating the medicine and the amount taken.
If you forget to take Loratadina Teva-ratiopharm
If you have any further questions on the use of this product, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking Loratadina Teva-ratiopharm and contact your doctor immediately if you notice any of the following:
Other side effects:
Very common (may affect up to 1 in 10 people) in adults and children over 12 years of age are:
Very common (may affect up to 1 in 10 people) in children aged 2 to 12 years are:
Very rare (may affect up to 1 in 10,000 people) side effects were also observed during the marketing of loratadine:
Frequency not known (cannot be estimated from the available data):
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not transfer the tablets to another container. Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
Do not use this medicine if you notice any change in the appearance of the tablet.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
This medicine does not require any special storage conditions.
Composition of Loratadina Teva-ratiopharm 10 mg
Appearance of the product and pack size
Loratadina Teva-ratiopharm 10 mg Tablets are white, oval, scored on one side and flat on the other, marked “L” and “10” on either side of the score line.
They are available in packs of 5, 7, 10, 15, 20, 28, 30, 50 and 100 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Teva Pharma, S.L.U.
C/ Anabel Segura 11 Edificio Albatros, 1ª planta
28108 Alcobendas, Madrid (Spain)
Manufacturer
Teva Pharmaceutical Works Private Limited Company Pallagi ut 13
4042 Debrecen
Hungary
or
Pharmachemie B.V.
Swensweg, 5. P.O. Box 552 (Haarlem) -2003
Netherlands
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Belgium Loratadine Teva 10 mg tablets
France LORATADINE TEVA 10 mg, tablet
Italy Loratadina Teva 10 mg tablets
Spain Loratadina Teva-ratiopharm 10 mg tablets EFG
United Kingdom (Northern Ireland) TEVA Loratadine 10 mg Tablets
Date of last revision of this leaflet:October 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and up-to-date information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/66530/P_66530.html
QR code + URL
The average price of LORATADINE TEVA-RATIOPHARM 10 mg TABLETS in November, 2025 is around 3.11 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LORATADINE TEVA-RATIOPHARM 10 mg TABLETS – subject to medical assessment and local rules.